Study advances on the role of CTRP9 in myocardial remodeling after myocardial

Home > Archive>Volume 30, Issue 2, 2022 >167-170

Study advances on the role of CTRP9 in myocardial remodeling after myocardial
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        MAO Shaobin1MAO Shaobin
Graduate School of Shanxi Medical University, Taiyuan, Shanxi 030000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
LIANG Bin2LIANG Bin
Department of Cardiovascular Medicine, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:1.Graduate School of Shanxi Medical University, Taiyuan, Shanxi 030000, China;2.Department of Cardiovascular Medicine, Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030000, China)
Clc Number:R5
Fund Project:

Article

Figures

Metrics

Reference [41]

Cited by

Materials

Comments

Abstract:

Myocardial remodeling after myocardial infarction is a complex pathological process, which seriously affects the prognosis of patients. CTRP9 is a newly discovered adipokine in recent years. A large number of studies have shown that CTRP9 can inhibit myocardial remodeling after myocardial infarction. This article reviews the related research of CTRP9 on myocardial remodeling after myocardial infarction.

Key words:CTRP9; myocardial infarction; myocardial remodeling

Reference

[1] KELLY D J, GERSHLICK T, WITZENBICHLER B, et al.Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction:the HORIZONS-AMI trial.Am Heart J, 1,2(4):663-670.

[2] KONSTAM M A, KRAMER D G, PATEL A R, et al.Left ventricular remodeling in heart failure:current concepts in clinical significance and assessment.JACC Cardiovasc Imaging, 1,4(1):98-108.

[3] COHN J N, FERRARI R, SHARPE N.Cardiac remodeling--concepts and clinical implications:a consensus paper from an international forum on cardiac remodeling.Behalf of an international forum on cardiac remodeling.J Am Coll Cardiol, 0,5(3):569-582.

[4] WONG G W, KRAWCZYK S A, KITIDIS-MITROKOSTAS C, et al.Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin.FASEB J, 9,3(1):241-258.

[5] APPARI M, BREITBART A, BRANDES F, et al.C1q-TNF-related protein-9 promotes cardiac hypertrophy and failure.Circ Res, 7,0(1):66-77.

[6] ZHENG Q, YUAN Y, YI W, et al.C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway.Arterioscler Thromb Vasc Biol, 1,1(11):2616-2623.

[7] KAMBARA T, SHIBATA R, OHASHI K, et al.C1q/tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism.Mol Cell Biol, 5,5(12):2173-2185.

[8] CHENG L, LI B, CHEN X, et al.CTRP9 induces mitochondrial biogenesis and protects high glucose-induced endothelial oxidative damage via AdipoR1-SIRT1-PGC-1α activation.Biochem Biophys Res Commun, 6,7(4):685-691.

[9] NIEMANN B, LI L, SIEGLER D, et al.CTRP9 mediates protective effects in cardiomyocytes via AMPK and adiponectin receptor-mediated induction of anti-oxidant response.Cells, 0,9(5):1229.

[10] YAN W, GUO Y, TAO L, et al.C1q/tumor necrosis factor-related protein-9 regulates the fate of implanted mesenchymal stem cells and mobilizes their protective effects against ischemic heart injury via multiple novel signaling pathways.Circulation, 7,6(22):2162-2177.

[11] YU X H, ZHANG D W, ZHENG X L, et al.C1q tumor necrosis factor-related protein 9 in atherosclerosis:mechanistic insights and therapeutic potential.Atherosclerosis, 8,6:109-116.

[12] JUNG T W, HONG H C, HWANG H J, et al.C1q/TNF-related protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.Mol Cell Endocrinol, 5,7:131-140.

[13] FRANGOGIANNIS N G.The inflammatory response in myocardial injury, repair, and remodelling.Nat Rev Cardiol, 4,1(5):255-265.

[14] WESTMAN P C, LIPINSKI M J, LUGER D, et al.Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction.J Am Coll Cardiol, 6,7(17):2050-2060.

[15] SAXENA A, RUSSO I, FRANGOGIANNIS N G.Inflammation as a therapeutic target in myocardial infarction:learning from past failures to meet future challenges.Transl Res, 6,7(1):152-166.

[16] LIU K, WANG J, GAO X, et al.C1q/TNF-related protein 9 inhibits coxsackievirus B3-induced injury in cardiomyocytes through NF-κB and TGF-β1/Smad2/3 by modulating THBS1.Mediators Inflamm, 2020:2540687.

[17] LIU M, YIN L, LI W, et al.C1q/TNF-related protein-9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction.J Cell Physiol, 9,4(10):18731-18747.

[18] JUNG C H, LEE M J, KANG Y M, et al.C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells.Mol Cell Endocrinol, 6,9:235-243.

[19] KAMBARA T, OHASHI K, SHIBATA R, et al.CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism.J Biol Chem, 2,7(23):18965-18973.

[20] GOMBOZHAPOVA A, ROGOVSKAYA Y, SHURUPOV V, et al.Macrophage activation and polarization in post-infarction cardiac remodeling.J Biomed Sci, 7,4(1):13.

[21] JY C, SONG C X, LEI S Y, et al.CTRP9 induces macrophages polarization into M1 phenotype through activating JNK pathway and enhances VSMCs apoptosis in macrophages and VSMCs co-culture system.Exp Cell Res, 0,5(1):112194.

[22] 吴学平, 李志宏, 王新艳, 等.心肌梗死后心脏修复与心肌细胞再生的研究进展.中国动脉硬化杂志, 9,7(10):899-904.

[23] VAN DEN BORNE S W, DIEZ J, WM B, et al.Myocardial remodeling after infarction:the role of myofibroblasts.Nat Rev Cardiol, 0,7(1):30-37.

[24] SHINDE A V, FRANGOGIANNIS N G.Fibroblasts in myocardial infarction:a role in inflammation and repair.J Mol Cell Cardiol, 4,0:74-82.

[25] ROMANOV A, MARTINEK M, PRERFELLNER H, et al.Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction:results of the ARREST study.Europace, 8,0(2):263-270.

[26] SCHMITT J, DURAY G, GERSH B J, et al.Atrial fibrillation in acute myocardial infarction:a systematic review of the incidence, clinical features and prognostic implications.Eur Heart J, 9,0(9):1038-1045.

[27] LIU M, LI W, WANG H, et al.CTRP9 ameliorates atrial inflammation, fibrosis, and vulnerability to atrial fibrillation in post-myocardial infarction rats.J Am Heart Assoc, 9,8(21):e013133.

[28] SUN Y, YI W, YUAN Y, et al.C1q/tumor necrosis factor-related protein-9, a novel adipocyte-derived cytokine, attenuates adverse remodeling in the ischemic mouse heart via protein kinase A activation.Circulation, 3,8(11 Suppl 1):S113-S120.

[29] LI Z, DU Y, JIA L, et al.Association of C1q/TNF-related protein-9 (CTRP9) level with obstructive sleep apnea in patients with coronary artery disease.Mediators Inflamm, 2020:7281391.

[30] DU Y, WANG X, LI L, et al.miRNA-Mediated suppression of a cardioprotective cardiokine as a novel mechanism exacerbating post-MI remodeling by sleep breathing disorders.Circ Res, 0,6(2):212-228.

[31] 刘丹勇, 夏正远, 韩荣辉, 等.心肌缺血再灌注损伤机制研究的回顾与展望.中国动脉硬化杂志, 0,8(12):1013-1019.

[32] SHAH A K, BHULLAR S K, ELIMBAN V, et al.Oxidative stress as a mechanism for functional alterations in cardiac hypertrophy and heart failure.Antioxidants (Basel), 1,0(6):931.

[33] SU L J, ZHANG J H, GOMEZ H, et al.Reactive oxygen species-induced lipid peroxidation in apoptosis, autophagy, and ferroptosis.Oxid Med Cell Longev, 2019:5080843.

[34] BECKER L B.New concepts in reactive oxygen species and cardiovascular reperfusion physiology.Cardiovasc Res, 4,1(3):461-470.

[35] MURDOCH C E, ZHANG M, CAVE A C, et al.NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.Cardiovasc Res, 6,1(2):208-215.

[36] MURDOCH C E, GRIEVE D J, CAVE A C, et al.NADPH oxidase and heart failure.Curr Opin Pharmacol, 6,6(2):148-153.

[37] LIN J M, HSU C H, CHEN J C, et al.Bcl-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury.Biofactors, 1,7(3):386-402.

[38] WENG C F, WU C F, KAO S H, et al.Down-regulation of miR-34a-5p potentiates protective effect of adipose-derived mesenchymal stem cells against ischemic myocardial infarction by stimulating the expression of C1q/tumor necrosis factor-related protein-9.Front Physiol, 9,0:1445.

[39] LIU D, GU G, GAN L, et al.Identification of a CTRP9 C-terminal polypeptide capable of enhancing bone-derived mesenchymal stem cell cardioprotection through promoting angiogenic exosome production.Redox Biol, 1,1:101929

[40] ZHAO D, FENG P, SUN Y, et al.Cardiac-derived CTRP9 protects against myocardial ischemia/reperfusion injury via calreticulin-dependent inhibition of apoptosis.Cell Death Dis, 8,9(7):723.

[41] ZUO A, LI J, ZHAO X, et al.Globular CTRP9 protects cardiomyocytes from palmitic acid-induced oxidative stress by enhancing autophagic flux.Chem Biol Interact, 0,9:109094.

Get Citation

MAO Shaobin, LIANG Bin. Study advances on the role of CTRP9 in myocardial remodeling after myocardial[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(2):167-170.

Copy

Article Metrics

Abstract:715
PDF: 787
HTML: 0
Cited by: 0

History

Received:March 25,2020
Revised:October 30,2021
Adopted:
Online: January 07,2022
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code